Table 4.
Mean MFAS Score over Time Evaluated by the Independent Blinded Raters (Full Analysis Set)
| YVOC (N = 80) | RESS (N = 80) | LS mean difference (95% CI) | |
|---|---|---|---|
| Baseline | 2.56 (0.05) | 2.56 (0.05) | 0.00 (−0.04 to 0.04) |
| Week 2 | 0.85 (0.07) | 0.90 (0.07) | 0.05 (0.00 to 0.10) |
| Week 14 | 1.02 (0.08) | 1.09 (0.08) | 0.06 (0.01 to 0.12) |
| Week 26 | 1.32 (0.07) | 1.39 (0.07) | 0.07 (0.01 to 0.12) |
| Week 52 | 1.84 (0.10) | 1.89 (0.10) | 0.05 (−0.02 to 0.13) |
Data are presented as LS mean (SE) unless otherwise indicated; data were analyzed using a mixed effects model including treatment and week as repeated measures effects and the subject as random effect; LS mean difference was calculated as RESs group—YVOC group.